The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded "Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables" to Abbott's diabetes care (division of Abbott Laboratories Limited), Advanced Therapeutics (UK) Ltd, Air Liquide Healthcare, with a value of £140.0m (29 September 2026).
The supply and delivery of Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables to all entities constituted pursuant to the National Health Service (Scotland) Act 1978, (i.e. All NHS Scotland Health Boards, Special Health Boards and the Authority). All NHS Northern Ireland Trusts.
A weekly round-up of new UK public sector contracts. No spam, unsubscribe any time.